Abstract
The presence of comorbidities (CM) in congenital lobar emphysema (CLE) has been previously described with varying rates. However, the clinical implication of CM on the clinical presentation and patient outcome in CLE is unclear. This was a retrospective cohort study between 2000 and 2022 in a single institution. The study included pediatric patients diagnosed with CLE. During the study period, 36 patients were identified with CLE. The presence of respiratory symptoms at diagnosis was documented in 69% (24/35) of the patients with 48% admitted to intensive care units. The presence of CM was documented in 14/36 (39%) of the patients, with cardiovascular anomalies as the most common (22%), followed by genitourinary anomalies (11%) and large airway anomalies (8%). When comparing the CM group (n = 14) vs the non-CM group (N = 22), there was no significant difference regarding gender, term birth, age of diagnosis, and the location of the lesion. The CM group had significantly higher rates of intensive care unit (ICU) admissions (75% vs 33%, p = 0.02), longer duration of admission (median 46 days vs 9, p = 0.02), and need for pre-operative non-invasive respiratory support (50% vs 5%, p = 0.002).
Conclusion: The presence of CM in CLE was associated with a more severe presentation as reflected with significantly higher rates of ICU admissions, prolonged admissions, and higher need for non-invasive respiratory support. Screening for CM, mostly for cardiac anomalies, is recommended at time of CLE diagnosis.
What is Known: • Congenital lobar emphysema (CLE) is a developmental lung anomaly generally associated with other comorbidities; however, their clinical implication on presentation is unclear • The prevalence of comorbidities in CLE was previously reported around 15–20%, with cardiovascular anomalies as the most common |
What is New: • Comorbidities are very common (39%) in CLE, and their presence is related to a more severe clinical presentation and need for respiratory support • Screening for comorbidities is recommended in CLE, specifically for cardiovascular and genitourinary anomalies |
Data availability
The data that support the findings of this study are not openly available due to reasons of sensitivity and are available from the corresponding author upon reasonable request.
Abbreviations
- CVS:
-
Cardiovascular
- CLE:
-
Congenital lobar emphysema
- CM:
-
Comorbidities
- GU:
-
Genitourinary
- ICU:
-
Intensive care unit
References
Demir OF, Hangul M, Kose M (2019) Congenital lobar emphysema: diagnosis and treatment options. Int J Chron Obstruct Pulmon Dis 1(14):921–928
Kunisaki SM, Saito JM, Fallat ME, Peter SD, Kim AG, Johnson KN et al (2019) Current operative management of congenital lobar emphysema in children: a report from the Midwest Pediatric Surgery Consortium. J Pediatr Surg 54(6):1138–1142
Abdel-Bary M, Abdel-Naser M, Okasha A, Zaki M, Abdel-Baseer K (2020) Clinical and surgical aspects of congenital lobar over-inflation: a single center retrospective study. J Cardiothorac Surg 15(1):102
Bush A, Chitty LYN, Harcourt J, Hewitt RJ, Nicholson AG (2019) “Congenital lung disease.” Kendig’s disorders of the respiratory tract in children. Elsevier 289–337.
Karnak I, Şenocak ME, Ciftci AO, Büyükpamukçu N (1999) Congenital lobar emphysema: diagnostic and therapeutic considerations. J Pediatr Surg 34(9):1347–1351
Mei-Zahav M, Konen O, Manson D, Langer JC (2006) Is congenital lobar emphysema a surgical disease? J Pediatr Surg 41(6):1058–1061
Gatt D, Lapidus-Krol E, Chiu PPL (2023) The long-term outcomes of symptomatic congenital lobar emphysema patients. Pediatr Pulmonol. https://doi.org/10.1002/ppul.26354
Elmaci TT, Güler N, Aydoğan U, Onursal E (2001) Infantile lobar emphysema and tracheal bronchus in a patient with congenital heart disease. J Pediatr Surg 36(10):1596–1598. https://doi.org/10.1053/jpsu.2001.27067
Hishitani T, Ogawa K, Hoshino K, Nakamura Y, Iwanaka T, Masago K et al (2003) Lobar emphysema due to ductus arteriosus compressing right upper bronchus in an infant with congenital heart disease. Ann Thorac Surg 75(4):1308–1310. https://doi.org/10.1016/s0003-4975(02)04623-4
Ozçelik U, Göçmen A, Kiper N, Doğru D, Dilber E, Yalçin EG (2003) Congenital lobar emphysema: evaluation and long-term follow-up of thirty cases at a single center. Pediatr Pulmonol 35(5):384–391. https://doi.org/10.1002/ppul.10240
Kunisaki SM, Saito JM, Fallat ME, St Peter SD, Kim AG, Johnson KN, Mon RA, Adams C, Aladegbami B, Bence C, Burns RC, Corkum KS, Deans KJ, Downard CD, Fraser JD, Gadepalli SK, Helmrath MA, Kabre R, Lal DR, Landman MP, Leys CM, Linden AF, Lopez JJ, Mak GZ, Minneci PC, Rademacher BL, Shaaban A, Walker SK, Wright TN, Hirschl RB (2019) Midwest Pediatric Surgery Consortium. Current operative management of congenital lobar emphysema in children: a report from the Midwest Pediatric Surgery Consortium. J Pediatr Surg 54(6):1138–1142. https://doi.org/10.1016/j.jpedsurg.2019.02.043
Cataneo DC, Rodrigues OR, Hasimoto EN, Schmidt AF Jr, Cataneo AJ (2013) Congenital lobar emphysema: 30-year case series in two university hospitals. J Bras Pneumol 39(4):418–26. https://doi.org/10.1590/S1806-37132013000400004
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by Dvir Gatt, Eveline Lapidus-Krol, and Priscilla P.L. Chiu. The first draft of the manuscript was written by Dvir Gatt. Eveline Lapidus-Krol and Priscilla P.L Chiu revised it critically for important intellectual content. All authors commented on previous versions of the manuscript. All authors read and approved the final manuscript and agreed to be accountable for all aspects of the work.
Corresponding authors
Ethics declarations
Ethics approval
This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by The Hospital for Sick Children’s research ethics board (REB 1000046012).
Competing interests
The authors declare no competing interests.
Additional information
Communicated by Peter de Winter
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Gatt, D., Lapidus-Krol, E. & Chiu, P.P.L. High comorbidity rates in congenital lobar emphysema and the effect on clinical presentation. Eur J Pediatr (2024). https://doi.org/10.1007/s00431-024-05684-3
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00431-024-05684-3